Givoudan developed MoodScentz and DreamScentz technologies to help improve the quality of GLP-1 consumers

Ozempic, Wegovy, Mounjaro are the names of these GLP-1-based medical treatments for diabetes and obesity have become commonplace. All around the world, their use is soaring and increasingly extending to aesthetic purposes, with significant implications for the beauty industry.
According to the various studies compiled by Givaudan, in the US, the proportion of adults using GLP-1 drugs to lose weight rose from 3% in 2024 to 11% in 2026.
The rise in obesity rates, steep cuts in treatment prices in some markets, the emergence of new molecules and the development of oral formulations – which are easier to use than injections – are all expected to further accelerate the adoption of GLP-1. There is a lot of talk about the weight people are losing with GLP-1 drugs, but much less about what consumers will want next. And that is where the real revolution is taking place. The fragrance and flavour specialists in Givoudan brought together the expertise of its Taste & Wellbeing and Fragrance & Beauty divisions in a creative exhibition exploring the theme ‘The New Desire’.

Consumers’ emerging concerns: temporary hair loss, bad breath, dry skin, skin laxity, and loss of facial volume (the well-known Ozempic face).

According presented by Givaudan, US households using GLP-1 drugs are shifting their spending away from food towards other categories such as beauty, sports, and travel. Their spending on fine fragrances has increased by 97%, a sign of the profound shift in their relationship with wellness and pleasure.

Key finding is that consumers want both pleasure and functional benefits that can help address the dips in mood and energy they experience. In this context, Givaudan highlights its patented MoodScentz technologies, developed through neuroscience research, as well as DreamScentz, designed to help improve the quality of sleep, which can be disrupted in some GLP-1 users.

Source link

3
Show Comments (0) Hide Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Recent Posts:
0
Would love your thoughts, please comment.x
()
x